SynthesisThe journal of headache and pain2026

Effectiveness and safety of anti-CGRP monoclonal antibodies in hemiplegic migraine: an individual patient quantitative analysis.

Marina Romozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.